Post

CHUV, CERN and THERYQ partner to develop cancer radiotherapy device

The new device will use very high-energy electron radiation to treat cancers that are resistant to conventional treatments.

Brainomix and Pixyl partner to offer multiple sclerosis solution

Neuro.MS is intended for the diagnosis and treatment of multiple sclerosis patients.

Boston Scientific reports initial data from ACURATE neo2 system study

Another observation from the study was a low 6.5% rate of new pacemaker implantation 30 days after procedures.